Inspira Announces Israeli Innovation Authority Grant For New VORTX Disposable Blood Oxygenation Technology; Inspira's VORTX Is As A Potential Frontrunner In The $4B Disposable Blood Oxygenator Market
Portfolio Pulse from Benzinga Newsdesk
Inspira Technologies has received a grant from the Israeli Innovation Authority (IIA) for its VORTX Disposable Blood Oxygenation Technology. The VORTX technology, which is being designed for compatibility with the INSPIRA ART Device line of products, is a potential frontrunner in the $4 billion disposable blood oxygenator market. The IIA has committed to supporting the VORTX development project by granting funds equal to 40% of the first-year IIA approved budget of $1 million.
November 06, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inspira Technologies has received a grant for its VORTX technology, potentially strengthening its position in the $4 billion disposable blood oxygenator market.
The grant from the IIA for the VORTX technology underscores the potential of Inspira's product in the disposable blood oxygenator market. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Inspira Technologies has received a grant for its VORTX technology, potentially strengthening its position in the $4 billion disposable blood oxygenator market.
The grant from the IIA for the VORTX technology underscores the potential of Inspira's product in the disposable blood oxygenator market. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100